IVAX Diagnostics Announces Going Concern Qualification

IVAX Diagnostics, Inc. IVD announced today that its audited consolidated financial statements for the fiscal year ended December 31, 2010, included in its Annual Report on Form 10-K which was filed with the Securities and Exchange Commission on March 30, 2011, contained a report from its independent registered public accounting firm that indicates there is a substantial doubt about IVAX Diagnostics' ability to continue as a going concern. This announcement is required by NYSE Amex Company Guide Section 610(b), which requires separate disclosure of receipt of an audit opinion containing a going concern qualification. This announcement does not represent any change or amendment to IVAX Diagnostics' consolidated financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2010.